[HTML][HTML] Explanation in artificial intelligence: Insights from the social sciences
T Miller - Artificial intelligence, 2019 - Elsevier
There has been a recent resurgence in the area of explainable artificial intelligence as
researchers and practitioners seek to provide more transparency to their algorithms. Much of this …
researchers and practitioners seek to provide more transparency to their algorithms. Much of this …
XAI—Explainable artificial intelligence
… https://orcid.org/0000-0002-4663-3263, Timothy Miller … Miller, Explanation in artificial
intelligence: Insights from the social sciences. Artif. Intell. … Timothy Miller https://orcid.org/0000-0003-4908-6063 …
intelligence: Insights from the social sciences. Artif. Intell. … Timothy Miller https://orcid.org/0000-0003-4908-6063 …
Histone deacetylases and cancer: causes and therapies
…, RA Rifkind, VM Richon, R Breslow, T Miller… - Nature Reviews …, 2001 - nature.com
Together, histone acetyltransferases and histone deacetylases (HDACs) determine the
acetylation status of histones. This acetylation affects the regulation of gene expression, and …
acetylation status of histones. This acetylation affects the regulation of gene expression, and …
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
…, TR Merriman, C Michaud, M Miller, TR Miller… - The lancet, 2012 - thelancet.com
Background Reliable and timely information on the leading causes of death in populations,
and how these are changing, is a crucial input into health policy debates. In the Global …
and how these are changing, is a crucial input into health policy debates. In the Global …
Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015
…, G Mensah, A Meretoja, H Mezgebe, T Miller… - Journal of the American …, 2017 - jacc.org
Background : The burden of cardiovascular diseases (CVDs) remains unclear in many regions
of the world. Objectives : The GBD (Global Burden of Disease) 2015 study integrated data …
of the world. Objectives : The GBD (Global Burden of Disease) 2015 study integrated data …
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to …
…, DT Mengiste, TJ Meretoja, TR Miller… - JAMA …, 2017 - jamanetwork.com
Importance Cancer is the second leading cause of death worldwide. Current estimates on
the burden of cancer are needed for cancer control planning. Objective To estimate mortality, …
the burden of cancer are needed for cancer control planning. Objective To estimate mortality, …
[HTML][HTML] The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
…, TM Grogan, TP Miller… - … England Journal of …, 2002 - Mass Medical Soc
Background The survival of patients with diffuse large-B-cell lymphoma after chemotherapy
is influenced by molecular features of the tumors. We used the gene-expression profiles of …
is influenced by molecular features of the tumors. We used the gene-expression profiles of …
[HTML][HTML] Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
…, W Mendoza, GBM Mensink, R Micha, TR Miller… - The lancet, 2019 - thelancet.com
Background Suboptimal diet is an important preventable risk factor for non-communicable
diseases (NCDs); however, its impact on the burden of NCDs has not been systematically …
diseases (NCDs); however, its impact on the burden of NCDs has not been systematically …
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors
Importance Understanding the major health problems in the United States and how they are
changing over time is critical for informing national health policy. Objectives To measure the …
changing over time is critical for informing national health policy. Objectives To measure the …
In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth …
…, J Sukbuntherng, RA Blake, L Sun, C Tang, T Miller… - Clinical cancer …, 2003 - AACR
One challenging aspect in the clinical development of molecularly targeted therapies, which
represent a new and promising approach to treating cancers, has been the identification of …
represent a new and promising approach to treating cancers, has been the identification of …